<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/1.5.2" -->
<rss version="0.92">
<channel>
	<title>PAIN RELIEF MEDICATIONS BLOG</title>
	<link>http://painreliefmedication.info</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Thu, 30 Aug 2007 20:12:30 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>

	<item>
		<title>The Foundation of Back Pain</title>
		<description>	8 out of 10 men and women will look for lower back pain relief at some point in their life.  Tenderness in the lower or middle back is the leading cause of disability and pain in people less than the age of 45.
	Back pain can vary from a gentle, ...</description>
		<link>http://painreliefmedication.info/2007/08/30/the-foundation-of-back-pain/</link>
	</item>
	<item>
		<title>Futura appoints adviser on pain relief</title>
		<description>	Consumer healthcare group Futura Medical, has appointed Professor Robert Moore DSc as an advisory consultant to the company in the therapeutic area of pain relief. The company said Prof Moore&#8217;s extensive experience of pain relief, from both academic and commercial perspectives, is expected to be of great value in the ...</description>
		<link>http://painreliefmedication.info/2007/08/23/futura-appoints-adviser-on-pain-relief/</link>
	</item>
	<item>
		<title>Roche Diagnostics&#8217; Test Helps Doctors Determine Appropriate Pain-Relief Treatment for Nursing Mothers</title>
		<description>	FDA Issues Advisory Warning Nursing Mothers of Potential Effects of Codeine While Nursing INDIANAPOLIS, Aug. 17 /PRNewswire/ &#8212; Nursing mothers can be tested with Roche Diagnostics&#8217; AmpliChip CYP450 Test to help their doctors determine whether they are ultra-rapid metabolizers of codeine. The Food &#038; Drug Administration issued a Public Health ...</description>
		<link>http://painreliefmedication.info/2007/08/18/roche-diagnostics-test-helps-doctors-determine-appropriate-pain-relief-treatment-for-nursing-mothers/</link>
	</item>
	<item>
		<title>Australian Drug Regulator Cancels Registration of Prexige</title>
		<description>	Australia’s drug regulator, the Therapeutic Goods Administration (TGA) has cancelled the registration of the osteoarthritis drug Prexige because of serious liver side effects associated with the use of the drug.
	According to the TGA, Novartis’ Prexige (lumiracoxib)  is a Cox 2 inhibitor belonging to the group of medicines known as ...</description>
		<link>http://painreliefmedication.info/2007/08/15/australian-drug-regulator-cancels-registration-of-prexige/</link>
	</item>
	<item>
		<title>Good Posture: Back Pain Relief</title>
		<description>	Having a good posture does not only make one&#8217;s personality more appealing but it keeps our bones and joints in the correct alignment to keep our muscles perform its movements normally and function excellently. Maintaining a good posture minimizes pressure on the spine, thus, the chance of getting backache and ...</description>
		<link>http://painreliefmedication.info/2007/08/07/good-posture-back-pain-relief/</link>
	</item>
	<item>
		<title>Pain relief drug ruled too costly for the NHS</title>
		<description>	Thousands of arthritis sufferers will be denied treatment with proven benefits by a decision not to pay for a new drug.
	Guidance issued by the National Institute for Health and Clinical Excellence (NICE), the watchdog that controls access to drugs on the NHS, will recommend today that the drug does not ...</description>
		<link>http://painreliefmedication.info/2007/08/02/pain-relief-drug-ruled-too-costly-for-the-nhs/</link>
	</item>
	<item>
		<title>Has Science Unearthed The Holy Grail Of Pain Relief?</title>
		<description>	The findings &#8212; published in the journal Nature &#8212; could rapidly advance research into the next generation of painkillers for relief of chronic conditions such as migraine and backache.
	Chronic pain, unlike the acute pain associated with trauma, has no apparent physiological benefit, often being referred to as the &#8216;disease of ...</description>
		<link>http://painreliefmedication.info/2007/07/26/has-science-unearthed-the-holy-grail-of-pain-relief-2/</link>
	</item>
	<item>
		<title>Health Canada expands use of new COX-2 inhibitor</title>
		<description>	Novartis Pharmaceuticals Canada Inc. announced today the expanded Health Canada approval of Prexige(*) (lumiracoxib) for the acute and chronic treatment of the signs and symptoms of osteoarthritis (OA) in adults. Initially approved for OA of the knee in November 2006, Prexige is a unique selective COX-2 inhibitor that provides osteoarthritis ...</description>
		<link>http://painreliefmedication.info/2007/07/25/health-canada-expands-use-of-new-cox-2-inhibitor/</link>
	</item>
	<item>
		<title>Implant Gives New Alternative For Neck Pain Relief</title>
		<description>	It used to be if you had a bad disc in your neck, the only solution was to remove it and fuse your vertebrae together.
	The recovery was long and it left patients with less ability to move their necks, but there’s a new alternative and a local hospital helped develop ...</description>
		<link>http://painreliefmedication.info/2007/07/21/implant-gives-new-alternative-for-neck-pain-relief/</link>
	</item>
	<item>
		<title>DURECT Reports Positive Results from POSIDUR(TM) Phase IIb Hernia Trial, Triggering $8 million Milestone Payment from Nycomed</title>
		<description>	DURECT Corporation announced today positive results from a 122 patient Phase IIb clinical trial of POSIDUR(TM) for treatment of post-operative pain in patients undergoing inguinal hernia repair. This Phase IIb trial was designed to be the study upon which DURECT and its collaborator Nycomed would base their decision for advancing ...</description>
		<link>http://painreliefmedication.info/2007/07/17/durect-reports-positive-results-from-posidurtm-phase-iib-hernia-trial-triggering-8-million-milestone-payment-from-nycomed/</link>
	</item>
</channel>
</rss>
